Health ❯ Healthcare ❯ Clinical Trials ❯ Drug Development

Phase 3 Trials

J&J Myeloma Trial Stopped Early After Tecvayli–Darzalex Shows PFS and OS Benefit

The company will present the full dataset to health authorities to seek use in earlier treatment lines.

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials